Schizophrenia: all 3,539 studies
Page 21 of 36. Open to participants first (473), then studies with results posted, then the rest; newest registration first within each.
- Cognate Patient Care Insight ScaleWithdrawnNCT03071939Not applicable
- Efficacy of Transcranial Direct Current Stimulation in Treatment of Cognitive Deficits in Early Stages of PsychosisStatus unknownNCT03071484Not applicable
- Brain Imaging, Attention, and Auditory Processing in SchizophreniaCompletedNCT03068806
- Study of m-RESIST, an m-Health Program for Treatment-resistant SchizophreniaCompletedNCT03064776Not applicable
- Enhancement of Treatment of Delusions in Schizophrenia Through NeuromodulationWithdrawnNCT03062553Not applicable
- Clonazepam Effects on Brain Oscillations and Cognition in SchizophreniaWithdrawnNCT03061136Phase 4
- Mobile Enhancement of Motivation in SchizophreniaCompletedNCT03059771Not applicable
- Emotional Response in Psychiatric and Control ParticipantsCompletedNCT03056781Not applicable
- Arithmetic Training With the Kumon Method for Cognition in SchizophreniaCompletedNCT03055520Not applicable
- Testing a New Device to Advance the Use of Social Skills Training With Mental Health Consumers and CliniciansCompletedNCT03053557Not applicable
- The Appeal and Impact of E-cigarettes in Smokers With SMICompletedNCT03050853Not applicable
- Goal Management Training for Patients With Schizophrenia or High Risk for SchizophreniaCompletedNCT03048695Not applicable
- Reactivity of the Vestibular System to Caloric Vestibular Stimulation in SchizophreniaCompletedNCT03048370Not applicable
- Raloxifene Augmentation in Patients With a Schizophrenia Spectrum DisorderCompletedNCT03043820Phase 3
- Future Mental Projections in SchizophreniaTerminatedNCT03040505
- Representations and Strategies for RecoveryCompletedNCT03028545Not applicable
- Sodium Butyrate For Improving Cognitive Function In SchizophreniaWithdrawnNCT03010865Phase 2/3
- Magnetic Seizure Therapy Versus Electroconvulsive Therapy for SchizophreniaCompletedNCT03007628Not applicable
- The Relevance Between the microRNA-30e in Plasma and the Prognosis of Schizophrenia PatientsStatus unknownNCT03007303
- Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in ItalyCompletedNCT03005769
- Comparing Thinking Skills for Work (TSW)Home Practice Program With Traditional TSW ProgramCompletedNCT03005574Not applicable
- 50 Hz vs. 25 Hz Magnetic Seizure Therapy for SchizophreniaCompletedNCT03003156Not applicable
- Evaluation of a Psychoeducation Program for Families Caregivers of Schizophrenic Patients : Randomized Study in Two ArmsStatus unknownNCT03000985Not applicable
- Magnesium Variations and Cardiometabolic Risk in Patients With Antipsychotic DrugsStatus unknownNCT02986490Not applicable
- Berberine as Adjuvant Treatment for Schizophrenia PatientsCompletedNCT02983188Phase 2/3
- Clinical Trial of AVL-3288 in Schizophrenia PatientsCompletedNCT02978599Phase 1
- RC2S+: Remediation of Social Cognitive ImpairmentsCompletedNCT02976077Not applicable
- Evaluation of Internet-based Cognitive Behavioral Self-help Treatments for People With PsychosisCompletedNCT02974400Not applicable
- The Impact of a Helplessness and Recovery of an Empowerment Intervention on People Diagnosed With Schizophrenia: Findings From a Randomized Controlled TrialCompletedNCT02968667Phase 2
- Safety and Tolerability Study of Single-dose Administration of Brexpiprazole in Adult Subjects With SchizophreniaTerminatedNCT02968121Phase 1
- Genes Polymorphisms and Metabolic Effects of the Second Generation Antipsychotic Drugs in Patients With SchizophreniaStatus unknownNCT02964923
- RCT Examining the Effectiveness of Digital Picture Frame Use in Inpatient SettingCompletedNCT02950571Not applicable
- Prednisolone Addition for Patients With Recent-onset Psychotic DisorderTerminatedNCT02949232Phase 4
- Music Therapy Towards Schizophrenia, Negative SymptomsStatus unknownNCT02942459Not applicable
- Berberine Effect on Cytokine, CRP, Metabolic Disturbance as an Adjunctive Therapy in Schizophrenia PatientsCompletedNCT02936414Not applicable
- The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic AgitationStatus unknownNCT02935998Phase 4
- A Study to Assess the pharmacoMRI Effects of AUT00206 in Healthy MalesCompletedNCT02935725Phase 1
- Endocannabinoid Control of Microglia Activation as a New Therapeutic Target in the Treatment of SchizophreniaCompletedNCT02932605Not applicable
- Evaluation of Metamemory Using a Semantic Construction Strategy in Patients With SchizophreniaStatus unknownNCT02932059Not applicable
- Validating Three Common Occupational Therapy Assessments in Participants With SchizophreniaCompletedNCT02930083
- The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and MechanismsCompletedNCT02928965Phase 2
- Low Pulse Amplitude Seizure Therapy (LAP-ST Study)CompletedNCT02928159Phase 1
- The Optimal Treatment for Treatment-resistant SchizophreniaStatus unknownNCT02926976Not applicable
- Enhancing Recovery in Early SchizophreniaActive, not recruitingNCT02926859Phase 2
- Schizophrenia and the Gut MicrobiomeCompletedNCT02921243
- Long-acting Paliperidone Palmitate Injection and Olanzapine for SchizophreniaCompletedNCT02918825Not applicable
- Cost-effectiveness of Interventions in First-episode PsychosisStatus unknownNCT02916303
- Potential Intervention Strategy With Folic Acid and Vitamin B12 in Patients With SchizophreniaStatus unknownNCT02916121Not applicable
- Minocycline add-on to Antipsychotics for the Treatment of Negative and Cognitive Symptoms in SchizophreniaStatus unknownNCT02907437Phase 3
- The Role of Nitric Oxide in Cognition in SchizophreniaCompletedNCT02906553Not applicable
- Magnetic Stimulation of the Brain in Schizophrenia or DepressionCompletedNCT02905604Not applicable
- Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective DisorderCompletedNCT02901587Phase 1
- Evaluation and Validation of Social Cognition Battery to Characterize Schizophrenic Patients FunctioningCompletedNCT02901015Not applicable
- Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia PatientsCompletedNCT02897167
- Normal and Abnormal ERP During ToM and Emotional Conflicts in SchizophreniaCompletedNCT02896374Not applicable
- Basic Auditory Processing and Auditory HallucinationsCompletedNCT02887794Not applicable
- Coronary Artery Disease in Patients Suffering From SchizophreniaStatus unknownNCT02885792Not applicable
- Mental Healthcare in Older Adults With SchizophreniaStatus unknownNCT02884739
- Predicting Antipsychotic Discontinuation in PsychosisStatus unknownNCT02884518Not applicable
- Tracking Outcomes in PsychosisStatus unknownNCT02882204
- [18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in PsychosisStatus unknownNCT02880995Not applicable
- A 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of SchizophreniaCompletedNCT02880462Phase 2
- Cost-utility Study of a Group of Compensatory Cognitive Remediation in SchizophreniaCompletedNCT02879604Not applicable
- Enhancing Social Interaction With an AlterEgo Artificial AgentStatus unknownNCT02879591Not applicable
- Evaluation of the Functional Remission Occurrence and Predictive Factors in SchizophreniaCompletedNCT02874560
- Cognitive and Emotional Factors in Visual Exploration Among Patients With SchizophreniaCompletedNCT02874482
- Anatomical and Structural Connectivity in Two Psychotic Phenotypes : Periodic Catatonia and CataphasiaCompletedNCT02868879
- Response Shift and Quality of Life in Patients Suffering From Schizophrenia and Their CaregiversStatus unknownNCT02868307Not applicable
- Cognitive Remediation Plus Aerobic Exercise in Schizophrenia TreatmentCompletedNCT02864576Not applicable
- Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Schizophrenia Patients With Auditory HallucinationsCompletedNCT02863094Not applicable
- Emotion and Motivation in Patients With PsychosisTerminatedNCT02853019Not applicable
- Trial and Follow-up of the Efficacy of Two-stage Integrated Treatment for Chinese Schizophrenia InpatientsStatus unknownNCT02850445Not applicable
- The Effects of tDCS on Illness Awareness in SchizophreniaCompletedNCT02848885Not applicable
- Repetitive Transcranial Magnetic Stimulation for the Treatment of Negative Symptoms in Schizophrenia Patients.Status unknownNCT02842034Not applicable
- Characterization of Emotional Processing of Information in Bipolar Disorder and Schizophrenic PatientsStatus unknownNCT02841345Not applicable
- Emotion Endophenotypes in SchizophreniaStatus unknownNCT02834208Not applicable
- fMRI of Theory of Mind in Schizophrenia and Bipolar DisorderStatus unknownNCT02834182Not applicable
- The Impact of Caffeine on Cognition in SchizophreniaCompletedNCT02832401Not applicable
- Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus TrospiumCompletedNCT02831231Phase 1
- "Manual Dexterity and Oculomotor Control in Schizophrenia"Status unknownNCT02826629Not applicable
- Study to Evaluate D2 Receptor Occupancy Following Single Intravenous Administration of ATI-9242CompletedNCT02824666Phase 1
- A Study to Evaluate The Effects of RO5545965 in Participants With Negative Symptoms of Schizophrenia Treated With AntipsychoticsCompletedNCT02824055Phase 1
- Efficacy and Mechanisms of Transcranial Direct Current Stimulation (tDCS) - Effects on Working Memory in SchizophreniaStatus unknownNCT02823639Not applicable
- Enhancing Cognitive Training Through Exercise Following a First Schizophrenia EpisodeCompletedNCT02823041Not applicable
- Texting for Relapse PreventionCompletedNCT02819349Not applicable
- Topiramate and Schizophrenia: Effects on Weight and PsychopathologyActive, not recruitingNCT02808533Not applicable
- Emotions in Schizophrenia and Bipolar Disorders: a Common Vulnerability?Status unknownNCT02805088Not applicable
- A Phase 1 Safety Study in Adults With SchizophreniaCompletedNCT02804568Phase 1
- The Efficacy of REHACOP Program in SchizophreniaCompletedNCT02796417Not applicable
- Efficacy and Mechanisms of Change of an Emotion-oriented Version of Cognitive-behavioral Therapy for PsychosisCompletedNCT02787135Not applicable
- Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With SchizophreniaCompletedNCT02787122Not applicable
- Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM)CompletedNCT02782442Not applicable
- Discriminant Validity of the Multiple Errands Test in SchizophreniaCompletedNCT02782091Not applicable
- Somatic Comorbidities in Psychiatric PatientsCompletedNCT02773108
- Glutamate, Learning, and Working MemoryCompletedNCT02769936Phase 1
- Single Ascending Dose Study of RBP-7000CompletedNCT02768649Phase 1
- Time,Self and Spontaneous Mental Activities in Patients With Psychotic DisordersTerminatedNCT02765880Not applicable
- First in Man Study of Safety, Tolerability and PK Profile of RBP-7000CompletedNCT02765555Phase 1
- Comparison of the Effectiveness of Brexpiprazole With That of RisperidoneWithdrawnNCT02758067Phase 3
- Connectomics in Psychiatric Classification of Bipolar Disorder and SchizophreniaCompletedNCT02756065